Latest filing published 27 Jan 2016 for Tvardi Therapeutics, Inc., €73k.
Insider track record
No signal scores available.
Michael E. Lewis: trading record in brief
Michael E. Lewis is a declared insider of Tvardi Therapeutics, Inc., with filings sourced from SEC (Form 4). The record holds 9 filings, for trades running from 5 February 2014 to 26 January 2016.
No open-market purchase appears, only 7 sales worth €483k. So far in 2016, the count stands at no purchases and 1 sale.
Most recently, on 27 January 2016, the filings show an open-market sale worth €73k in Tvardi Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Michael E. Lewis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,262 shares@ US$10.93100.0% of flowCommon StockSEC:0001209191-16-093830:0
- 7,262 shares@ US$11.66Common StockSEC:0001209191-15-059607:0
- 7,262 shares@ US$9.50Common StockSEC:0001209191-15-049115:0
- 7,262 shares@ US$10.64Common StockSEC:0001209191-15-038916:0
- 7,262 shares@ US$9.90Common StockSEC:0001209191-15-031681:0
- 7,262 shares@ US$10.11Common StockSEC:0001209191-15-021759:0
- 7,262 shares@ US$10.60Common StockSEC:0001209191-15-008991:0
- 40,000 shares0Common StockSEC:0001209191-14-007611:0
- 3,572 shares0Common StockSEC:0001209191-14-007611:1
9 of 9 declarations